Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04464174
Title Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer (PATHFINDER)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedSIR
Indications

triple-receptor negative breast cancer

Therapies

Eribulin + Ipatasertib

Capecitabine + Ipatasertib

Carboplatin + Gemcitabine + Ipatasertib

Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.